Latest Breaking News On - Lantern pharma daily - Page 1 : vimarsana.com

Lantern Pharma (LTRN) Scheduled to Post Earnings on Thursday

Lantern Pharma (LTRN) Scheduled to Post Earnings on Thursday
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Aarongl fletcherLantern pharma incSecurities exchange commissionLantern pharmaGet free reportExchange commissionPharma incLantern pharma daily

Lantern Pharma (NASDAQ:LTRN) Receives Neutral Rating from HC Wainwright

HC Wainwright reaffirmed their neutral rating on shares of Lantern Pharma (NASDAQ:LTRN – Free Report) in a research note published on Thursday morning, Benzinga reports. Lantern Pharma Stock Performance Shares of NASDAQ LTRN opened at $5.46 on Thursday. Lantern Pharma has a 12 month low of $2.38 and a 12 month high of $11.99. The […]

Aarongl fletcherSecurities exchange commissionMeridian wealth managementLantern pharma incLantern pharmaFree reportGet free reportExchange commissionWealth managementPharma incLantern pharma daily

Lantern Pharma (LTRN) Set to Announce Quarterly Earnings on Wednesday

Lantern Pharma (NASDAQ:LTRN – Get Free Report) will be posting its quarterly earnings results after the market closes on Wednesday, August 9th. Analysts expect Lantern Pharma to post earnings of ($0.40) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link. Lantern […]

Renaissance technologiesLantern pharma incLantern pharma company profileCommonwealth equity servicesLantern pharmaGet free reportPharma trading downEquity servicesStreet groupState street corpStreet corpPharma incLantern pharma dailyNasdaq ltrn

Lantern Pharma (NASDAQ:LTRN) Trading Up 8%

Lantern Pharma Inc. (NASDAQ:LTRN – Get Rating)’s stock price was up 8% during mid-day trading on Monday . The stock traded as high as $5.85 and last traded at $5.83. Approximately 130,592 shares were traded during mid-day trading, an increase of 304% from the average daily volume of 32,361 shares. The stock had previously closed […]

Renaissance technologiesNewedge advisorsJpmorgan chase coLantern pharma incLynwood capital management incEf hutton acquisition coLantern pharmaGet ratingPharma stock downEdge advisorsStreet corpLynwood capital managementPharma incLantern pharma dailyNasdaq ltrn

Lantern Pharma Inc (NASDAQ:LTRN) Forecasted to Post Q2 2023 Earnings of ($0 40) Per Share

Lantern Pharma Inc. (NASDAQ:LTRN – Get Rating) – Equities researchers at Zacks Small Cap issued their Q2 2023 earnings estimates for Lantern Pharma in a report released on Wednesday, May 10th. Zacks Small Cap analyst J. Vandermosten expects that the company will earn ($0.40) per share for the quarter. The consensus estimate for Lantern Pharma’s […]

Lantern pharma incEf hutton acquisition coRenaissance technologiesLynwood capital management incLantern pharma company profileJpmorgan chase coLantern pharmaGet ratingZacks small capSmall capPharma trading downCapital managementJane street groupPharma incLantern pharma dailyNasdaq ltrn